Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities
Abstract COVID-19 caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and other respiratory viral (non-CoV-2-RV) infections are associated with thrombotic complications. The differences in prothrombotic potential between SARS-CoV-2 and non-CoV-2-RV have not been well characterised...
Guardado en:
Autores principales: | Chuen Wen Tan, Jing Yuan Tan, Wan Hui Wong, May Anne Cheong, Ian Matthias Ng, Edwin Philip Conceicao, Jenny Guek Hong Low, Heng Joo Ng, Lai Heng Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2647185d83a24b5cb2c6ab9dddd87f8d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comorbidities and crash involvement among younger and older drivers.
por: Michela Papa, et al.
Publicado: (2014) -
Serum hypercoagulability states in Coats’ disease
por: Ghassemi F, et al.
Publicado: (2017) -
Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
por: Abu Saleh Md Moin, et al.
Publicado: (2021) -
Neutrophil extracellular traps induce a hypercoagulable state in glioma
por: Shihua Zhang, et al.
Publicado: (2021) -
Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population
por: M Keith Rawlings, et al.
Publicado: (2011)